Search results for: 'Life Science Tools and Diagnostics'

Rapid development in digitalization and technological achievements as propelled augmented reality (AR) and virtual reality (VR) beyond the experimental stage. In recent years, the field of AR/VR technology has experienced exponential growth due to its ability to bridge the gap between the physical and digital worlds. However, the technology faces s...

The Sensor Technology Opportunity Engine provides profiles of innovations related to AI-driven multimodal sensor fusion platforms enabling autonomous perimeter security and threat detection; AI-enabled portable hyperspectral imaging platforms for real-time field inspection and material analysis; ultra-low-noise scientific CMOS sensors for high-prec...

This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as wit...

The study analyses the Turkish healthcare landscape, market outlook and growth opportunities by covering private healthcare services, pharmaceuticals, medical devices, medical imaging and clinical diagnostics segments. Rapid economic growth and healthcare transformation program generated a significant increase in healthcare expenditure in Turkey. T...

12 Aug 2020  |  North America  |  Market Research

Strategic Commercial Partnerships Transforming the Global Biobanking Market, 2020–2026

Precision Medicine Applications and Value-based Data Pricing with Pharma and Health-tech to Trigger Market Growth

Infographics

×

The biobanking ecosystem is witnessing significant transformation. Emergence of one-stop shops and virtual biobanks, rise in services offered to sustain and improve positioning, and precision medicine are characterizing this transformative environment. The biobanking market is expected to reach a size of ~$71.2 billion by 2026, registering a compou...

Healthcare expenditure in Singapore is expected to grow, fueled by factors such as rising incomes and a progressively aging population. Diagnostics has emerged as a way for earlier and better identification of diseases to control rising healthcare costs in Singapore. Hence, the country has become a natural choice for many global diagnostic companie...

Laboratory personnel were invited to participate in an online survey in June 2014. A total of 366 laboratory decision makers qualified to complete the survey, answering questions about their use of laboratory information management systems (LIMS). Respondents organization types include academic laboratory or core facility; federal, state, or local...

This report focuses on the dynamic radiopharmaceuticals (diagnostics and therapeutics) market including additional analysis of the FDG and Radiopharmacy segments. The report covers the markets for agents over an eleven year period, from 1998 to 2008, with the year 2001 as the base year. This report provides a comprehensive analysis of the revenue...

In the rapidly evolving landscape of 2024, where technological advancements are accelerating, the ability to identify, invest in, and leverage these advancements is becoming increasingly critical for organizations aiming to maintain industry leadership and ensure sustainable growth. Recognizing this imperative, Frost & Sullivan launches the 14t...